Table 7 Disease-specific survival (DSS) according to clinical stage and recurrence status
From: Melanoma characteristics in Brazil: demographics, treatment, and survival analysis
Variable | Category | n | 5-year DSS (%) | p |
|---|---|---|---|---|
T | T1 | 203 | 93.1 | <0.001 |
T2 | 175 | 75.9 | ||
T3 | 162 | 59.6 | ||
T4 | 204 | 53.1 | ||
N | N0 | 577 | 80.3 | < 0.001 |
N1 | 81 | 52.3 | ||
N2 | 63 | 43.3 | ||
N3 | 78 | 27.8 | ||
M | M0 | 732 | 72.4 | < 0.001 |
M1 | 105 | 26.1 | ||
Clinical stage (TNM) | I | 277 | 91.4 | |
II | 257 | 70.1 | ||
III | 198 | 46.5 | ||
IV | 105 | 26.1 | ||
Distant recurrence | Absent | 653 | 87.9 | < 0.001 |
Visceral | 177 | 18.4 | ||
Non-visceral | 53 | 35.9 | ||
Locoregional recurrence | Yes | 122 | 33.5 | < 0.001 |
No | 753 | 74.8 | ||
Serum lactate dehydrogenase | ≤480 IU/L | 614 | 74.0 | <0.001 |
>480 IU/L | 102 | 55.4 |